导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 6.65% | -0.04% | -0.0027% |
| 300677 | 英科医疗 | 4.32% | 5.79% | 0.2501% |
| 301015 | 百洋医药 | 4.15% | 2.47% | 0.1025% |
| 000423 | 东阿阿胶 | 3.96% | 1.64% | 0.0649% |
| 002422 | 科伦药业 | 3.96% | 3.41% | 0.1350% |
| 000403 | 派林生物 | 2.78% | -1.61% | -0.0448% |
| 300705 | 九典制药 | 2.77% | 1.49% | 0.0413% |
| 300765 | 新诺威 | 2.74% | 1.63% | 0.0447% |
| 688253 | 英诺特 | 2.32% | 0.39% | 0.0090% |
| 688062 | 迈威生物 | 2.17% | -0.67% | -0.0145% |
| 重仓股合计:35.82%, 重仓股贡献增长率: 0.5855%, 总持股仓位:83.07%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-30 | 0.93% | 0.84% |
| 2024-04-29 | 0.80% | 0.58% |
| 2024-04-26 | 1.68% | 1.74% |
| 2024-04-25 | 1.31% | 1.08% |
| 2024-04-24 | 0.94% | 0.69% |
| 2024-04-23 | 0.51% | -0.03% |
| 2024-04-22 | 1.13% | 0.59% |
| 2024-04-19 | -0.37% | -0.72% |
| 基金名称 | 单位净值 | 增长率 |
| 建信恒生科技指数发起(QDII)A | 1.1305 | 2.4127% |
| 建信恒生科技指数发起(QDII)C | 1.1245 | 2.4127% |
| 建信医疗健康行业股票A | 1.0852 | 0.8443% |
| 建信医疗健康行业股票C | 1.0750 | 0.8443% |
| 建信港股通精选混合A | 0.8016 | 0.7281% |
| 建信港股通精选混合C | 0.7933 | 0.7281% |
| 建信中证500 | 2.5388 | 0.6281% |
| 300红利 | 1.3241 | 0.3968% |
| 建信高端医疗股票 | 1.4649 | 0.3678% |
| 建信中证红利潜力指数A | 1.3090 | 0.3568% |
